Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.
Year: 1995
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: L M Weiner, J I Clark, M Davey, W S Li, I Garcia de Palazzo, D B Ring, R K Alpaugh
Institution: Fox Chase Cancer Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2111931010